This audit would examine the effectiveness of the National Blood Authority’s management of the blood supply system and blood products, including plasma products.

Governments in Australia spend over $1 billion per year on the supply of blood and blood products, with 63 per cent provided by the Australian Government. Forty-four per cent of all immunoglobulin used in 2016–17 had to be bought from overseas suppliers, and whiledemand is rising by 11 per cent per year, local collections are rising by only five per cent.